Tag: GWPH

Cannabis Earnings Season Kickoff Reveals Mixed Trends

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$7.5 million per...
- November 17th, 2019 at 2:06 pm

Getting Over the Hemp Hump

You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
- November 10th, 2019 at 10:55 am

How to Position for the Cannabis Capital Crunch

You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
- September 29th, 2019 at 10:56 am

Cannabis Stocks Retreat in May

After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
- June 3rd, 2019 at 8:39 am

Why Some New Cannabis Stocks Flop

This is a copy of the May 12th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, “The next Tilray”. This was a phrase...
- May 12th, 2019 at 9:26 am

GW Pharma Raises $300 Million at $158 per Share

GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $300 Million LONDON and CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc...
- October 2nd, 2018 at 8:48 pm

GW Pharma to Raise $300 Million

GW Pharmaceuticals Announces Proposed Public Offering of ADSs LONDON and CARLSBAD, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”),...
- October 1st, 2018 at 4:19 pm